Barclays (LON:BARC) analyst David E. Strauss maintained a Buy rating on Leidos Holdings (NYSE:LDOS) on Monday, setting a price target of $115, which is approximately 10.07% above the present share price of $104.48.
E. Strauss expects Leidos Holdings to post earnings per share (EPS) of $1.44 for the second quarter of 2021.
The current consensus among 10 TipRanks analysts is for a Strong Buy rating of shares in Leidos Holdings, with an average price target of $115.33.
The analysts price targets range from a high of $125 to a low of $100.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $3.32 billion and a net profit of $308 million. The company's market cap is $14.78 billion.
According to TipRanks.com, Barclays analyst David E. Strauss is currently ranked with 1 stars on a 0-5 stars ranking scale, with an average return of -0.5% and a 53.33% success rate.
Leidos Holdings, Inc. is a holding company, which engages in the provision of scientific, engineering and information technology services and solutions in the areas of defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment focuses on deploying agile, cost-effective solutions to meet the ever-changing missions of the company's customers in areas of intelligence surveillance and reconnaissance, enterprise IT and integrated systems and cybersecurity and global services. The Civil segment focuses on seamlessly integrating and protecting physical, digital and data domains. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.